Hirofumi Shirakawa

Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival

Yu Sawada, Toshiaki Yoshikawa, Daisuke Nobuoka et al. · Clinical Cancer Research · 2012 · 299 citations

Medicine, Immunology, Oncology +17

Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP-05).

Michiaki Unno, Fuyuhiko Motoi, Yutaka Matsuyama et al. · Journal of Clinical Oncology · 2019 · 283 citations

Medicine, Surgery, Medical Oncology +14

Glypican‐3 expression is correlated with poor prognosis in hepatocellular carcinoma

Hirofumi Shirakawa, Hitomi Suzuki, Manami Shimomura et al. · Cancer Science · 2009 · 276 citations · Full text

Medicine, Oncology, Pathology +17

Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial

Kohei Nakachi, Masafumi Ikeda, Masaru Konishi et al. · The Lancet · 2023 · 232 citations

Medicine, Oncology, Surgery +11

Effectiveness of Etoposide and Cisplatin vs Irinotecan and Cisplatin Therapy for Patients With Advanced Neuroendocrine Carcinoma of the Digestive System

Chigusa Morizane, Nozomu Machida, Yoshitaka Honma et al. · JAMA Oncology · 2022 · 93 citations · Full text

Medicine, Oncology, Pharmacology +16